Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel D S, Castanas E
Laboratory of Experimental Endocrinology, University of Crete, School of Medicine and University Hospital, Heraklion, Greece.
J Cell Biochem. 1996 Dec 15;63(4):410-21. doi: 10.1002/(SICI)1097-4644(19961215)63:4%3C410::AID-JCB3%3E3.0.CO;2-W.
Opioids and somatostatin analogs have been implicated in the modulation of renal water handling, but whether their action is accomplished through central and/or peripheral mechanisms remains controversial. In different cell systems, on the other hand, opioids and somatostatin inhibit cell proliferation. In the present study, we have used an established cell line, derived from opossum kidney (OK) proximal tubules, in order to characterize opioid and somatostatin receptors and to investigate the action of opioids and somatostatin on tubular epithelial tissue. Our results show the presence of one class of opioid binding sites with kappa, selectivity (KD 4.6 +/- 0.9 nM, 57,250 sites/cell), whereas delta, mu, or other subtypes of the kappa site were absent. Somatostatin presents also a high affinity site on these cells (KD 24.5 nM, 330,000 sites/cell). No effect of either opioids or somatostatin on the activity of the NA+/Pi cotransporter was observed, indicating that these agents do not affect ion transport mechanisms. However, opioid agonists and somatostatin analogs decrease OK cell proliferation in a dose-dependent manner; in the same nanomolar concentration range, they displayed reversible specific binding for these agents. The addition of diprenorphine, a general opioid antagonist, reversed the effects of opioids, with the exception of morphine. Furthermore, morphine interacts with the somatostatin receptor in this cell line too, as was the case in the breast cancer T47D cell line. Our results indicate that in the proximal tubule opioids and somatostatin do not affect transport, but they might have a role in the modulation of renal cell proliferation either during ontogenesis or in kidney repair.
阿片类药物和生长抑素类似物与肾水代谢调节有关,但它们的作用是通过中枢和/或外周机制实现的,这一点仍存在争议。另一方面,在不同的细胞系统中,阿片类药物和生长抑素会抑制细胞增殖。在本研究中,我们使用了一种源自负鼠肾(OK)近端小管的成熟细胞系,以表征阿片类药物和生长抑素受体,并研究阿片类药物和生长抑素对肾小管上皮组织的作用。我们的结果显示存在一类具有κ选择性的阿片类结合位点(KD 4.6±0.9 nM,57,250个位点/细胞),而不存在δ、μ或κ位点的其他亚型。生长抑素在这些细胞上也呈现出一个高亲和力位点(KD 24.5 nM,330,000个位点/细胞)。未观察到阿片类药物或生长抑素对Na+/Pi共转运体活性的影响,这表明这些药物不影响离子转运机制。然而,阿片类激动剂和生长抑素类似物以剂量依赖的方式降低OK细胞增殖;在相同的纳摩尔浓度范围内,它们对这些药物表现出可逆的特异性结合。除吗啡外,通用阿片类拮抗剂二丙诺啡的添加可逆转阿片类药物的作用。此外,吗啡在该细胞系中也与生长抑素受体相互作用,乳腺癌T47D细胞系中也是如此。我们的结果表明,在近端小管中,阿片类药物和生长抑素不影响转运,但它们可能在个体发育或肾脏修复过程中对肾细胞增殖的调节中发挥作用。